Immunotherapy of primary liver cancer. A control study of 51 patients.
D002759:Adenoma, Bile Duct / Q000188:drug therapy*; D000328:Adult; D001650:Bile Duct Neoplasms / Q000188:drug therapy*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D007978:Levamisole